glp-1 news today 2025 november 6 Weight-loss drug makers announce pricing agreement with Trump The Underappreciated Benefits of GLP-1

The renewed energy

Miller AA, Spencer SJ

The letter authors urged clinicians to be aware of the adverse effects of drugs like Ozempic on the small intestine

(31) Discussion The findings from this literature review suggest that GLP-1 receptor agonists influence bone metabolism, wound healing, and surgical outcomes, with both preclinical and clinical evidence supporting potential benefits in orthopedic settings

During the first three quarters of 2025, Mounjaro sales nearly doubled (up 94%) from $8.010 billion to $15.558 billion, including $6.515 billion garnered in Q3 (more than double a year earlier)while Zepbound sales tripled from $3.018 billion to $9.281 billion, including $3.588 billion racked up in the July-September quarter, nearly triple (185%) Q3 2024